Literature DB >> 9764937

Clinical and in situ cellular responses to Haemophilus ducreyi in the presence or absence of HIV infection.

R King1, S H Choudhri, J Nasio, J Gough, N J Nagelkerke, F A Plummer, J O Ndinya-Achola, A R Ronald.   

Abstract

We aimed to determine if the clinical and histological features of chancroid are altered by HIV infection. Male patients presenting to the Nairobi special treatment clinic with a clinical diagnosis of chancroid were eligible for the study. A detailed history, physical examination, swabs for Haemophilus ducreyi culture and blood for HIV serology, syphilis serology and CD4 counts were obtained from all patients. Punch biopsies from an ulcer were obtained from 10 patients and either fixed in 10% formalin or snap frozen in Optimum Cutting Temperature (OCT) medium compound at -70 degrees C. Patients were treated with erythromycin and followed for 3 weeks. Chi-square and Student's t-test were used to determine if the clinical and laboratory features of chancroid differed between HIV-seropositive and seronegative individuals. Cox regression survival analysis was used to determine if HIV infection altered cure rates of chancroid at 21 days. Immunohistochemical staining was performed using lymphocytic and macrophage markers and tissue sections were analysed by 2 pathologists in a blinded manner. Between February and November 1994, 109 HIV-seropositive and 211 HIV-seronegative individuals were enrolled in the study. HIV patients had ulcers of longer duration than HIV-seronegative patients (P=0.03). Although cure rates were similar at 3 weeks, HIV patients had lower cure rates at 1 week (23% v 54%, P=0.002). A dense interstitial and perivascular inflammatory infiltrate extending from the reticular to deep dermis was present in all biopsies. This consisted of equal amounts of CD4 and CD8 T-lymphocytes as well as macrophages. The histological and immunohistochemical picture was identical for HIV-positive and negative patients. HIV infection slows the healing rates of chancroid ulcers despite appropriate antibiotic therapy. This clinical difference cannot be attributed to an altered histopathological response to HIV infection. Additional studies are needed to elucidate the mechanisms responsible for this finding.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Antibiotics--therapeutic use; Biology; Chancroid; Cytologic Effects; Demographic Factors; Developing Countries; Diseases; Drugs; Eastern Africa; English Speaking Africa; Histochemical Effects; Hiv Infections; Infections; Kenya; Physiology; Population; Population Characteristics; Reproductive Tract Infections; Research Report; Sexually Transmitted Diseases; Treatment; Urban Population; Viral Diseases

Mesh:

Year:  1998        PMID: 9764937     DOI: 10.1258/0956462981922773

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  10 in total

Review 1.  Diagnostic tests for chancroid.

Authors:  D A Lewis
Journal:  Sex Transm Infect       Date:  2000-04       Impact factor: 3.519

Review 2.  Immunopathogenesis of Haemophilus ducreyi infection (chancroid).

Authors:  Stanley M Spinola; Margaret E Bauer; Robert S Munson
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

3.  Expression of Haemophilus ducreyi collagen binding outer membrane protein NcaA is required for virulence in swine and human challenge models of chancroid.

Authors:  Robert A Fulcher; Leah E Cole; Diane M Janowicz; Kristen L Toffer; Kate R Fortney; Barry P Katz; Paul E Orndorff; Stanley M Spinola; Thomas H Kawula
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

4.  Haemophilus ducreyi inhibits phagocytosis by U-937 cells, a human macrophage-like cell line.

Authors:  G E Wood; S M Dutro; P A Totten
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

5.  Experimental infection with Haemophilus ducreyi in persons who are infected with HIV does not cause local or augment systemic viral replication.

Authors:  Diane M Janowicz; Klara Tenner-Racz; Paul Racz; Tricia L Humphreys; Carol Schnizlein-Bick; Kate R Fortney; Beth Zwickl; Barry P Katz; James J Campbell; David D Ho; Stanley M Spinola
Journal:  J Infect Dis       Date:  2007-04-05       Impact factor: 5.226

6.  Characterization of Haemophilus ducreyi-specific T-cell lines from lesions of experimentally infected human subjects.

Authors:  V Gelfanova; T L Humphreys; S M Spinola
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

7.  Trafficking pathways and characterization of CD4 and CD8 cells recruited to the skin of humans experimentally infected with Haemophilus ducreyi.

Authors:  Tricia L Humphreys; Lee Ann Baldridge; Steven D Billings; James J Campbell; Stanley M Spinola
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

8.  The cytolethal distending toxin of Haemophilus ducreyi inhibits endothelial cell proliferation.

Authors:  Liselott A Svensson; Petra Henning; Teresa Lagergård
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

9.  Expression of cytolethal distending toxin and hemolysin is not required for pustule formation by Haemophilus ducreyi in human volunteers.

Authors:  R S Young; K R Fortney; V Gelfanova; C L Phillips; B P Katz; A F Hood; J L Latimer; R S Munson; E J Hansen; S M Spinola
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 10.  Chancroid: clinical manifestations, diagnosis, and management.

Authors:  D A Lewis
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.